SQI gains approval for celiac disease test in Canada

02/25/2014 | GenomeWeb Daily News (free registration)

SQI Diagnostics has received the go-ahead in Canada to market its Ig_plex Celiac DGP Panel for clinical lab use. The multiplexed panel, which runs on the company's sqid-X platform, is designed to help clinicians rapidly detect celiac disease by quantifying key biomarkers linked to the illness, CEO Andrew Morris said.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN